Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Genitourinary 2Gastrointestinal 2Tumor-Agnostic 1Sarcoma 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Hypoxia 1Head and Neck Neoplasms 1

Interventions

Cisplatin 620pembrolizumab 323Radiotherapy 319Cetuximab 275Docetaxel 221Radiotherapy, Intensity-Modulated 210Carboplatin 197Fluorouracil 196Paclitaxel 159Nivolumab 138Gemcitabine 124Magnetic Resonance Spectroscopy 94Radiation 85Drug Therapy 77Capecitabine 76toripalimab 75Surgical Procedures, Operative 62durvalumab 60Biopsy 52Cyclophosphamide 50Chemoradiotherapy 47camrelizumab 46Specimen Handling 46Erlotinib Hydrochloride 46Radiosurgery 45130-nm albumin-bound paclitaxel 44Standard of Care 43tislelizumab 42Platinum 41Bevacizumab 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × pimonidazole × Head & Neck × Clear all
NCT06085781 2026-03-05

HN-BIO

University Health Network, Toronto

Phase NA Recruiting
60 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT02414048 2016-06-17

Hypoxia Analysis in Head and/or Neck Cancer

University of Zurich

Phase 2 Unknown
10 enrolled
Head & Neck

Hypoxia, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡